MedTrace Logo

Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis

NCT01426347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2017-03-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the effect of vitamin D repletion on disease activity and disability in patients with rheumatoid arthritis.

The investigators hypothesize that rheumatoid arthritis (RA) patients with vitamin D deficiency have greater disease activity and disability, compared to RA patients with normal vitamin D levels. The investigators also hypothesize that vitamin D treatment in these deficient patients will result in a decrease in RA disease activity and disability.

Conditions

Interventions

DRUG

Placebo sugar pill

Intervention includes 1 sugar pill once a week for 16 weeks dispensed as a capsule.

DRUG

Ergocalciferol

Ergocalciferol 50,000 IU per week for 16 weeks

Sponsors & Collaborators

Principal Investigators

  • Uzma J Haque, M.D. · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01426347 on ClinicalTrials.gov